Team:Waterloo

From 2014.igem.org

(Difference between revisions)
m
 
(3 intermediate revisions not shown)
Line 12: Line 12:
<div class="blueOnGrey">
<div class="blueOnGrey">
<h1>Staphylocide</h1>
<h1>Staphylocide</h1>
-
<h3 style="text-align: center">Delivering Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation</h3>
+
<h3 style="text-align: center">Delivery of an Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation</h3>
</div>
</div>
<!--Content below images-->
<!--Content below images-->
Line 30: Line 30:
</div>
</div>
</div>
</div>
 +
<p>&nbsp;</p>
<!-- here go the centered images -->
<!-- here go the centered images -->
<h2 class="centerUpper blueOnGrey" style="margin-left: 2%; margin-right: 2%; margin-top: 80;"">Project Cornerstones</h2>
<h2 class="centerUpper blueOnGrey" style="margin-left: 2%; margin-right: 2%; margin-top: 80;"">Project Cornerstones</h2>

Latest revision as of 02:33, 18 October 2014

Waterloo iGem 2014 Team

Staphylocide

Delivery of an Antibiotic Resistance Gene Silencing Mechanism to a MRSA Population using Bacterial Conjugation

Problem

MRSA is sweeping the nation, an antibiotic-resistant scourge migrating from hospitals into communities. We need a hero to fight it and Waterloo iGEM has designed a synthetic bacterium that just might do the trick...

Solution

...Staphylocide! Staphylocide delivers antibiotic resistance gene silencing in vivo and could one day be incorporated into a treatment that would help doctors defeat MRSA once and for all.

 

Project Cornerstones

Explore the three cornerstones of this year's project: delivering the silencing in vivo using conjugation, silencing mecA expression using CRISPRi and sRNA and translating from the lab to the patients.